HSL Mobile App 
52 week Low
-
-
52 week High
-
-
31.05
Day low
31.05
31.05
Day high
33.60
33.60
31.05
Prev Close
-
-
Open
32.86
32.86
6M return
0.00%
0.00%
1Y return
0.00%
0.00%
MCap(Rs. in Cr.)
770.11
770.11
Total Volume
2,72,000
2,72,000
Face Value : 1
Listed Since 22 Mar 2023
PE Ratio
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
P/E RATIO
66.66667
EPS
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
EPS
0.48
PRICE/BOOK
Price-to-book ratio is used to compared the company's current market price with its book value.
PRICE/BOOK
6.69
Deliverable
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
DELIVERABLES
100%
DIV YIELD.(%)
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
DIV YIELD.(%)
0.09
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
Technical
The key levels help you plan your entry and exit point.
-
PROFIT & LOSS
Take a quick look at the revenues and expenditure sheet.
-
Balance Sheet
Its a statement of assets, liabilities and share capital.
-
Dividend History
Check out the detailed payout data over the last three years.
-
Comparative Returns
Reveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
Resistance 1
-
-
Resistance 2
-
-
Support 1
-
-
Support 2
-
-
Moving Average
20 Days
-
-
50 Days
-
-
100 Days
-
-
200 Days
-
-
Growth in 3 years
Sales
29.81%
Sales Industry Avg
27.21%
PAT
118.29%
PAT Industry Avg
177.23%
29.81%
Sales Industry Avg
27.21%
PAT
118.29%
PAT Industry Avg
177.23%
| FY 2024 ( in Cr.) | |
|---|---|
| Sales | 463.54 |
| Gross Profit | 16.47 |
| Operating Profit | 0 |
| Profit Before Tax | 15.24 |
| Tax | 3.78 |
| Profit After Tax | 11.46 |
Growth in 3 years
Total Asset Growth
261.11%
Total Liabilities growth
258.65%
Reserves Change
337.54%
261.11%
Total Liabilities growth
258.65%
Reserves Change
337.54%
| Mar 2024 ( in Cr.) | Mar 2023 ( in Cr.) | Mar 2022 ( in Cr.) | Mar 2021 ( in Cr.) | Mar 2020 ( in Cr.) | |
|---|---|---|---|---|---|
| Share Capital | 24.07 | 24.07 | 9.75 | 9.55 | 9.55 |
| Reserves And Surplus | 87.64 | 76.91 | 20.03 | 12.96 | 10.29 |
| Investments | 13.84 | 12.34 | 0 | 0 | 0.04 |
| Total Debt | 104.84 | 34.10 | 30.60 | 29.77 | 20.81 |
| Total Liabilities | 216.55 | 135.08 | 60.38 | 52.33 | 40.65 |
| Total Assets | 214.79 | 133.53 | 59.48 | 46.94 | 34.98 |
3%
Dividend
Date:25 Aug 2023
Dividend Percentage:3
Dividend Type:Final
2023
2024 2025
2026
Relative to Sensex rtn in 3 year
-100.00%
Relative to Nifty rtn in 3 year
-100.00%
Relative to top 3 MF rtn in 3 year
-100.00%
Relative to Nifty rtn in 3 year
-100.00%
Relative to top 3 MF rtn in 3 year
| 1 Year (%) | 2 Year (%) | 3 Year (%) | |
|---|---|---|---|
| Sudarshan Pharma | 0 | 0 | 0 |
| Bse Sensex | -0 | 23 | 40 |
| Nifty 50 | -0 | 27 | 42 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Sudarshan Pharma
31.05 chg : 31.05 (0.00%)
31.05 chg : 31.05 (0.00%)
Shiv Texchem
236.20 chg : 236.20 (0.00%)
236.20 chg : 236.20 (0.00%)
Khemani Distrib.
157.50 chg : 157.50 (0.00%)
157.50 chg : 157.50 (0.00%)
Sunrise Efficie.
167.00 chg : 167.00 (0.00%)
167.00 chg : 167.00 (0.00%)
Prime Fresh
118.30 chg : 118.30 (0.00%)
118.30 chg : 118.30 (0.00%)
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
My investment would be worth 1,00,000.00 with a Gain of 0.00%
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
No data available
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
D
2023 Dividend
Date:25 Aug 2023
Dividend Percentage:3
S
2024 Split
Date : 22 Nov 2024
Split Ratio : 1:10
2025
Our Research Analysis
As of today
__PERCENT__%
Target Achived
__PERCENT__%
Target Achived
This call still has potential to give significant positive returns
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
CMP : __CMP__
Target : __TARGET__
Stop Loss : __STOPLOSS__
Reco Price : __RECOPRICE__
Reco Date :__RECODATE__
Call Type :__CALLTYPE__
__Rationale__
__RECOTYPE__ __COMPANY_NAME__
|
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
Our View __RECOTYPE__
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
| No data available |
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
| Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
|---|---|---|---|
| No data available | |||
News
Stay tuned to the latest developments and happenings in the company.
Sudarshan Pharma Industries to convene EGM
Sudarshan Pharma Industries announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 4 February 2025.Powered by....
11 Jan 2025 17:22Sudarshan Pharma Industries to convene board meeting
Sudarshan Pharma Industries will hold a meeting of the Board of Directors of the Company on 10 January 2025.Powered by Capital Market - ....
07 Jan 2025 10:09Sudarshan Pharma Industries to table results
Sudarshan Pharma Industries will hold a meeting of the Board of Directors of the Company on 31 October 2024Powered by Capital Market - L....
26 Oct 2024 10:29__heading__
Published on __date__ at __time__
__description__
